Latest Equities News

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.

Yowie Group has posted its first profitable seasonal quarter, driven by strategic cost control and product improvements, but faces ongoing capital challenges due to a significant loan default by Keybridge Capital.

Dateline Resources Limited has updated its scoping study for the Colosseum Gold Project in California, incorporating a revised gold price of US$2,900/oz that significantly enhances the project's economic outlook. The study confirms robust project fundamentals and sets the stage for a Definitive Feasibility Study.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Jameson Resources has announced a $3.5 million equity raise to advance its Crown Mountain Hard Coking Coal Project in British Columbia, supported by a positive feasibility update and strong government backing amid geopolitical trade tensions.

Surefire Resources NL has launched a non-renounceable entitlement offer aiming to raise approximately A$3.87 million to advance its gold and copper projects in Western Australia. The offer includes new shares, bonus shares, and options, targeting eligible shareholders in Australia and New Zealand.

Credit Clear Limited confirms it remains on track to meet its FY25 earnings guidance, buoyed by strong client growth and cost-cutting measures, even as revenue forecasts are revised downward due to timing delays.

Elders Limited reported a robust half-year performance for the period ending 31 March 2025, with profit after tax surging 190% to $33.6 million and revenue rising 5% to $1.41 billion. The company’s growth was driven by strong livestock prices, real estate acquisitions, and disciplined cost management.

Elders Limited has announced a fully franked ordinary dividend of AUD 0.18 per share for the half-year ending March 2025, accompanied by a Dividend Reinvestment Plan offering a 1.5% discount on new shares.

Osteopore Limited has drawn down an additional A$500,000 from the first tranche of its redeemable convertible notes, bringing total subscriptions close to the A$5 million tranche limit. The funds will support ongoing operations and future growth initiatives.